Long-Term Outcomes of True versus Non-True Coronary Bifurcation Lesions Treated with Bioresorbable Polymer Sirolimus-Eluting Ultimaster Stent

Long-Term Outcomes of True versus Non-True Coronary Bifurcation Lesions Treated with Bioresorbable Polymer Sirolimus-Eluting Ultimaster Stent - Bifurcation post hoc analysis of the SCVC registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055953

Enrollment

440

Registered

2024-10-26

Start date

2024-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Of 1727 cases enrolled in the SCVC registry, bifurcation lesions treated with bioresorbable polymer sirolimus-eluting Ultimaster stent were included in this study.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Target vessel failure (TVF), defined as a composite of cardiac death, target-vessel related myocardial infarction (TVMI), and clinically driven target vessel revascularization (CDTVR).	—

Countries

Japan

Contacts

Public ContactShoichi Kuramitsu

Sapporo Cardiovascular Clinic Cardiovascular Medicine

kuramitsu@heart-kizuna.com0117847847

Outcome results